This website has been funded and developed by Abbvie and is intended for UK audiences only. 

Helping people to live with CLL

MyCLLife is a campaign to support and empower people whose lives have been impacted by chronic lymphocytic leukaemia (CLL). Whether you are living with or know someone living with CLL, this website is dedicated to help you play an active role in your or their care.


A campaign developed by the CLL community for the CLL community


MyCLLife is a disease awareness initiative developed and funded by AbbVie, with input and support from the CLL community.

 

We are immensely proud that MyCLLife has been created with insights from a group of people living with CLL, care partners, UK patient groups and leading healthcare professionals specialising in the treatment of blood cancers.


Our mission is simple – to help people live with CLL

MyCLLife provides useful information, insights, guidance, and practical tips from the wider CLL community to help people living with CLL to play an active role in their care so they can live with CLL.

 

All the resources have been co-created with the CLL community to help people navigate and manage the complex nature of CLL, encourage informed conversations with healthcare professionals, and most importantly – to bring comfort and support to those who need it.


Remember, everyone’s experience of CLL is different and there is no ‘normal’.

You should always speak with a healthcare team about any medical concerns you have.

We’ve been involved in the MyCLLife campaign for many years and are proud to see the impact the materials, information and resources have on the community. At CLL Support Association, we strive to provide helpful resources to those living with CLL and empower them to make the right decisions for them in their CLL journey.

 

When we shared the MyCLLife Preparing for Treatment Discussions Guide with our community, we had several members commenting on how they used it successfully to discuss their care with their doctors, and others wished the guide had been available earlier when they had faced difficult discussions and decisions about their care.


Hilary Lindsay, Chair, CLL Support Association

Our Resources


MyCLLife has many resources to help to understand and manage a CLL diagnosis. Here are all the resources in one place:


Booklets



Videos


Chronic Lymphocytic Leukaemia (CLL) Through the Lens


MyCLLife: How to talk to your doctor about active monitoring and chronic lymphocytic leukaemia



Living with Chronic Lymphocytic Leukaemia


Our CLL stories




Podcasts


My CLLife: Patients discuss life with Chronic Lymphocytic Leukaemia (CLL)


Caring for a loved one with Chronic Lymphocytic Leukaemia (CLL)




Mindfulness resources


Mindfulness for blood cancer patients: an introduction


Mindfulness of the Body



Mindfulness of soles of the feet


Mindfulness of the breath


Further Support

We are proud to work with UK patient groups that provide a wealth of information, resources, and support for those affected by CLL.

 
Please note, clicking the logos will take you to external websites that are not managed or owned by AbbVie.
UK-ONCC-240014 | July 2024
This website has been developed and funded by AbbVie and is intended for UK audiences only. This resource is not intended to provide or replace expert medical advice. Please consult your healthcare professional for further information.
Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of a medicine.

 

@2024 AbbVie Ltd. AbbVie House, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UB. UK Telephone: +44 (0) 1628 561 090. All rights reserved. Registered number: 08004972
MyCLLife is a disease awareness initiative developed and funded by AbbVie, with input and support from the CLL community.
 
Privacy Policy | Terms of Use
UK-ONCC-240012 | July 2024